Main
            
                            
                Perm. 1
                Haven 
            
                    
                Perm. 2
                Icebox 
            
                    
                Perm. 3
                Bind 
            
            kda
                        +/-
                        ACS
                        Pering. 3.0
                        KAST
                        ADR
                        hs%
                        Dampak
                        fk
                        fd
                        F+/-
                        mk
                        Perdag.
                        Kopl.
                    
                                    53 / 48 / 5
                                                                    
                                
                                    +5
                                                                    
                                
                                    221.22
                                                                    
                                
                                    1.10
                                                                    
                                
                                    57.80%
                                                                    
                                
                                    135.84
                                                                    
                                
                                    22%
                                                                    
                                
                                    254
                                                                    
                                
                                    11
                                                                    
                                
                                    8
                                                                    
                                
                                    +3
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    44 / 51 / 11
                                                                    
                                
                                    -7
                                                                    
                                
                                    196.47
                                                                    
                                
                                    0.97
                                                                    
                                
                                    60.89%
                                                                    
                                
                                    134.80
                                                                    
                                
                                    33%
                                                                    
                                
                                    203
                                                                    
                                
                                    8
                                                                    
                                
                                    17
                                                                    
                                
                                    -9
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    41 / 46 / 21
                                                                    
                                
                                    -5
                                                                    
                                
                                    195.20
                                                                    
                                
                                    0.95
                                                                    
                                
                                    70.13%
                                                                    
                                
                                    138.47
                                                                    
                                
                                    43%
                                                                    
                                
                                    55
                                                                    
                                
                                    2
                                                                    
                                
                                    7
                                                                    
                                
                                    -5
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    38 / 46 / 27
                                                                    
                                
                                    -8
                                                                    
                                
                                    178.27
                                                                    
                                
                                    0.87
                                                                    
                                
                                    71.92%
                                                                    
                                
                                    120.72
                                                                    
                                
                                    28%
                                                                    
                                
                                    2
                                                                    
                                
                                    -
                                                                    
                                
                                    2
                                                                    
                                
                                    -2
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    32 / 46 / 24
                                                                    
                                
                                    -14
                                                                    
                                
                                    149.31
                                                                    
                                
                                    0.74
                                                                    
                                
                                    59.48%
                                                                    
                                
                                    92.20
                                                                    
                                
                                    42%
                                                                    
                                
                                    100
                                                                    
                                
                                    4
                                                                    
                                
                                    5
                                                                    
                                
                                    -1
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            kda
                        +/-
                        ACS
                        Pering. 3.0
                        KAST
                        ADR
                        hs%
                        Dampak
                        fk
                        fd
                        F+/-
                        mk
                        Perdag.
                        Kopl.
                    
                                    50 / 36 / 20
                                                                    
                                
                                    +14
                                                                    
                                
                                    211.78
                                                                    
                                
                                    1.21
                                                                    
                                
                                    78.19%
                                                                    
                                
                                    129.19
                                                                    
                                
                                    33%
                                                                    
                                
                                    224
                                                                    
                                
                                    10
                                                                    
                                
                                    2
                                                                    
                                
                                    +8
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    51 / 43 / 29
                                                                    
                                
                                    +8
                                                                    
                                
                                    254.58
                                                                    
                                
                                    1.16
                                                                    
                                
                                    75.34%
                                                                    
                                
                                    166.84
                                                                    
                                
                                    23%
                                                                    
                                
                                    187
                                                                    
                                
                                    8
                                                                    
                                
                                    2
                                                                    
                                
                                    +6
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    53 / 42 / 18
                                                                    
                                
                                    +11
                                                                    
                                
                                    210.86
                                                                    
                                
                                    1.15
                                                                    
                                
                                    70.06%
                                                                    
                                
                                    129.02
                                                                    
                                
                                    24%
                                                                    
                                
                                    148
                                                                    
                                
                                    7
                                                                    
                                
                                    7
                                                                    
                                
                                    0
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    43 / 47 / 14
                                                                    
                                
                                    -4
                                                                    
                                
                                    208.72
                                                                    
                                
                                    1.00
                                                                    
                                
                                    70.42%
                                                                    
                                
                                    140.89
                                                                    
                                
                                    17%
                                                                    
                                
                                    248
                                                                    
                                
                                    11
                                                                    
                                
                                    7
                                                                    
                                
                                    +4
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    40 / 40 / 12
                                                                    
                                
                                    0
                                                                    
                                
                                    174.27
                                                                    
                                
                                    0.93
                                                                    
                                
                                    75.09%
                                                                    
                                
                                    128.36
                                                                    
                                
                                    23%
                                                                    
                                
                                    74
                                                                    
                                
                                    3
                                                                    
                                
                                    7
                                                                    
                                
                                    -4
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            Bandar taruhan
                    
                        HZ
                        vs
                        Bleed
                    
                Pertandingan sebelumnya
Pertandingan sebelumnya
Tanggal
                Pertandingan
                Acara
            
                                    
                    
                        
                            2022-03-27 03:30:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        1
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                XERXIA
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                    
                    
                        
                            2022-03-26 07:55:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        0
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                Paper Rex
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-03-25 03:30:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                FULL SENSE
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                    
                    
                        
                            2022-03-24 06:00:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                MI Thailand
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-03-16 10:10:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                NAOS Esp
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: APAC Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-02-27 06:00:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        0
                                    
                                    -
                                    
                                        3
                                    
                                                            
                            
                                Paper Rex
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-02-27 03:30:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        0
                                    
                                                            
                            
                                No Namers
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                        
                        
                    
                                                                                
                    
                        
                            2022-02-26 11:00:00
                        
                        
                        
                            
                                
                                Bleed
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                HZ
                                
                            
                        
                        
                            VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                        
                        
                    
                            
        Informasi acara
                    VALORANT Champions Tour 2022: Malaysia & Singapore Stage 1 Challengers
                    
                                                    2022-02-10 00:00:00
                            -
                            2022-02-27 00:00:00
                                            
                
            
                    34
                    Pert.
                
                                    
                        $23,828
                        Pusat hadiah
                    
                                
                    B-Tier
                    Tingkat
                
            
                                    Group A
                                
                                                            
                                    Group B
                                
                                                            
                                    Group C
                                
                                                            
                                    Group D
                                
                                                    Group A
            Pert.
            Rounds
            RD